The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Inclusion Criteria:

• Age above 18 years old
• ILD according to ATS/ERS guidelines
• Signed inform consent

Exclusion Criteria:

• Previous lung surgery
• Other significant systemic disease